Home
>
US Stocks
>
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH

Lantheus Holdings Inc (LNTH)

$23.111.72%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$22.99
Today Low/High$22.91 / $23.22
52 Week Low/High$10.52 / $28.74
P/E ratio-56.59
Market Cap$1.56B

Company Details

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow™ serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.
OrganisationLantheus Holdings Inc
HeadquatersNorth Billerica, Massachusetts, US
Employees595
IndustryHealth Technology
CEOMary Heino

Discover more

Frequently Asked Questions

What is Lantheus Holdings Inc (LNTH) share price today?

Can Indians buy Lantheus Holdings Inc (LNTH) shares?

How can I buy Lantheus Holdings Inc (LNTH) shares from India?

Can Fractional shares of Lantheus Holdings Inc (LNTH) be purchased?

What are the documents required to start investing in Lantheus Holdings Inc (LNTH) stocks?

We are a SEBI registered investement advisor